Literature DB >> 3259479

Alpha 1-antichymotrypsin microheterogeneity in crossed immunoaffinoelectrophoresis with free concanavalin A: a useful diagnostic tool in inflammatory syndrome.

E Hachulla1, A Laine, A Hayem.   

Abstract

Using crossed immunoaffinoelectrophoresis with free concanavalin A (Con A) in the first dimension and alpha-methyl-D-glucoside incorporated in the second-dimension gel, we examined the microheterogeneity of alpha 1-antichymotrypsin (alpha 1Achy) in sera from healthy donors (N) and in sera from patients with various inflammatory syndromes. We studied three groups: patients with acute inflammation (myocardial infarction: MI, septic inflammation: SI), patients with chronic inflammation (metastatic breast cancer: MBC), and patients with chronic inflammation accompanied by acute attacks (connective-tissue disease: CTD). All pathological sera had a high alpha 1Achy concentration. Compared with N, MI and SI showed an increased proportion of Con A-reactive fraction and a decreased proportion of Con A-nonreactive fraction, which was more pronounced in SI. Unlike the patients with acute inflammation, patients with CTD showed an increased proportion of Con A-nonreactive fraction. Thus alpha 1Achy microheterogeneity in crossed immunoaffinoelectrophoresis may afford a means of differentiating between various inflammatory syndromes. In particular, it can provide a simple test: if the Con A-nonreactive fraction is in a proportion less than 17%, septic origin of an acute-phase reaction may be suspected.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3259479

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  5 in total

1.  Does methotrexate affect serum level of IgA-alpha-1 antitrypsin complex in early rheumatoid arthritis?

Authors:  J K Lacki; T Schochat; K Klama; S H Mackiewicz; W Müller
Journal:  Clin Rheumatol       Date:  1995-09       Impact factor: 2.980

2.  Transforming growth factor beta 1 influences glycosylation of alpha 1-protease inhibitor in human hepatoma cell lines.

Authors:  A Mackiewicz; I Kushner
Journal:  Inflammation       Date:  1990-10       Impact factor: 4.092

Review 3.  Glycoforms of serum alpha 1-acid glycoprotein as markers of inflammation and cancer.

Authors:  A Mackiewicz; K Mackiewicz
Journal:  Glycoconj J       Date:  1995-06       Impact factor: 2.916

4.  Altered glycosylation profile of purified plasma ACT from Alzheimer's disease.

Authors:  Manuela Ianni; Marcella Manerba; Giuseppina Di Stefano; Elisa Porcellini; Martina Chiappelli; Ilaria Carbone; Federico Licastro
Journal:  Immun Ageing       Date:  2010-12-16       Impact factor: 6.400

5.  In-depth Site-specific Analysis of N-glycoproteome in Human Cerebrospinal Fluid and Glycosylation Landscape Changes in Alzheimer's Disease.

Authors:  Zhengwei Chen; Qinying Yu; Qing Yu; Jillian Johnson; Richard Shipman; Xiaofang Zhong; Junfeng Huang; Sanjay Asthana; Cynthia Carlsson; Ozioma Okonkwo; Lingjun Li
Journal:  Mol Cell Proteomics       Date:  2021-04-20       Impact factor: 5.911

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.